(14:40 GMT) Guardant Health Price Target Raised to $200.00/Share From $175.00 by Bernstein
DO Dow Jones Newswires Guardant Health Is Maintained at Outperform by Bernstein 7/2/2026, 10:40 PM GMT+8 Dow Jones Newswires GH GH (14:40 GMT) Guardant Health Price Target Raised to $200.00/Share From $175.00 by Bernstein Market News Dow Jones Newswires Correction to When Multi-Cancer Blood Screens Could Finally Take Off — Barrons.com Dow Jones Newswires When Multi-Cancer Blood Screens Could Finally Take Off — Barrons.com Stocktwits GH Stock At Over 5-Year Highs – What’s The UnitedHealth Connection? Dow Jones Newswires Guardant Health Is Maintained at Buy by BTIG
